Nancy L. Hedges
Thanks, Pete, and good afternoon, everyone. I will walk through our fourth quarter and full year results in more detail, provide some color by segment, review cash flow and the balance sheet, and then close with key financial priorities. As Pete noted, we delivered on our expectations of a step change improvement in revenue growth in the fourth quarter. The 15.1% revenue growth also drove strong operational results. Gross profit increased nearly 29% to $80,000,000 and gross margin expanded 350 basis points year over year to 33.3%. The majority of margin expansion was the result of higher volume and favorable mix. This included a surge in aircraft spares orders that we expect will benefit the first quarter as well. The 2025 period also benefited year over year from repricing actions taken throughout 2025. Margin was also supported by some normal course catch-up pricing on a couple programs, overall productivity gains, and the benefit of earlier Test Systems restructuring actions, which more than offset the $2,900,000 of increased tariff expenses. R&D expense was $10,600,000 or 4.4% of sales, which is within an expected 4% to 5% run rate. Levels can vary from quarter to quarter based on the timing of projects. The $7,300,000 decline in SG&A expense was primarily the result of a $9,000,000 reduction in legal reserves and litigation-related expenses. SG&A included the incremental SG&A expense gained from the Buehler acquisition as well as the one-time legal and accounting costs related to it. At 14.1% of sales, we were at the lower end of our historic operating rate of 14% to 15% of sales. We expect to continue to benefit from lower litigation expenses and the cost saving measures we have implemented. Stronger gross profit and lower operating expenses flow through to operating income, which was $35,500,000, up sharply from $8,900,000 a year ago, and operating margin expansion of 10.5 points to 14.8%. On an adjusted basis, which excludes the acquisition expenses and continued litigation costs, operating income was $38,300,000 and adjusted operating margin expanded 450 basis points to 16%. We had solid conversion to net income, which was $29,000,000 or $0.78 per diluted share in the quarter, compared with a loss in the prior year period. I do want to point out that our diluted shares for the 2025 fourth quarter included 1,400,000 shares associated with the assumed shares underlying the remaining 5.5% convertible bonds, as the average share price for the quarter was above the conversion price on those bonds. However, there was no diluted EPS effect in the quarter related to the 0% new convertible bonds, as the average share price was below the $54.87 conversion price. As a reminder, we do have a capped call in place, which means that there is no actual potential dilution unless and until our share price exceeds $83.41, after which potential dilution comes on gradually beyond that price. Nonetheless, the calculation for the diluted average weighted share count will reflect the implicated shares associated only with the premium on the bonds, as long as the quarter's average share price exceeds the $54.87 conversion price. Adjusted net income was $28,500,000 or $0.75 per diluted share, which is lower than the GAAP reported net income as a result of normalizing the quarter's tax rate. The volume, mix, reduced litigation expenses, and pricing recovery benefited Aerospace operating profit in the quarter, which was $41,700,000 or about 2.5 times greater than the prior year period, and resulted in operating margin of 19% of sales. On an adjusted basis, Aerospace operating profit margin expanded 380 basis points to 19%. Even on a relatively low level of sales, Test Systems produced operating profit of $1,100,000 compared with slightly below breakeven results a year ago. The improvement reflects the benefit of simplification and restructuring actions taken in 2024 and 2025, partially offset by continued unfavorable mix and under-absorption of fixed costs at our current volume. We expect profitability to improve meaningfully once production on the U.S. Army radio test program ramps. Before we turn to the balance sheet, I wanted to touch on tariffs for a moment. As you all know, the U.S. Supreme Court held a imposed under the International Emergency Economic Powers Act or IEEPA exceeded the authority granted by that statute. We are reviewing this decision with our advisers to understand any implications for previously paid tariffs, and our go-forward cost structure, but at this time, we are not assuming any benefit in the outlook. To date, we have treated these tariffs as a normal cost of doing business, and have not recognized any asset for potential refunds. Time will tell if there will be an opportunity to recoup any or all of the approximately $8,000,000 in incremental tariffs previously paid. We will, of course, be monitoring the situation closely. Now moving on to cash and the balance sheet. We had a strong cash quarter and generated $27,600,000 in cash from operations in the quarter, and $74,800,000 for the year. Strong cash earnings in the quarter were partially offset by higher working capital to support increased order volume. Operating cash flow also included a tenant improvement allowance reimbursement of $5,000,000 for the quarter, which is offset by the CapEx in the buildout and consolidation for our new Redmond, Washington facility. For the year, we had $8,000,000 in reimbursements. Capital expenditures were $11,800,000 in the quarter, and $31,700,000 for the year. We still have some work to do on the Seattle facility consolidation, so there will be carryover into 2026. We are expecting CapEx of $40,000,000 to $50,000,000 for 2026. Not included in that number is approximately $14,000,000 to $18,000,000 of investment into a global enterprise resource planning system. Because of the accounting treatment for those types of projects, that spend will not be reflected in CapEx, but instead will come through as cash outflow from operations. We are planning a staged implementation of the ERP. Excuse me. And the project is projected to take approximately five years to complete, with the cost expected to be heaviest in 2026. We will be relying on both outside resources and a dedicated team to execute on the implementation. We closed the year with $18,200,000 in cash and cash equivalents, net debt was $324,800,000 at the end of the year, up from $156,600,000 at the end of 2024. The increase reflects the refinancing actions that we executed in September 2025 that included the repurchase of 80% of the $165,000,000 principal 5.5% convertible bonds, which required $285,800,000 given how far in the money those bonds were at the time. We also purchased a capped call for $26,900,000 which elevated the strike price on the new bonds issued to $83.41. To pay for the repurchase in the capped call, we issued $225,000,000 of 0% convertible bonds, we borrowed on our revolver, and we used cash on hand. As Pete mentioned, in October, we also entered into a new $300,000,000 senior secured cash-flow-based revolving credit facility, of which we had $85,000,000 drawn at year end. We closed the year with $231,000,000 in available liquidity, including the remaining available on the revolver and $18,000,000 in cash. Our capital allocation priorities remain oriented on funding organic growth and critical capacity and infrastructure investments, while maintaining a prudent and flexible balance sheet. We believe our current capital structure, improved profitability, and healthy liquidity position us well to execute on these priorities. Our financial priorities for 2026 include to deliver on our revenue outlook, supported by a record backlog and strong demand in Aerospace, drive further operating margin expansion with an emphasis on achieving sustainable high-teens operating margins or better over time, improved Test Systems profitability as volume ramps on the Army Radio Test Set Program, and to maintain a strong liquidity position while investing in our future. With that, we are pleased with the progress we made in 2025 and the foundation that we have built for 2026 and beyond. Pete, I will turn it back to you to discuss our outlook. Thank you, Nancy.